{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T17:51:53Z","timestamp":1780509113026,"version":"3.54.1"},"reference-count":74,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ackdjournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Chronic Kidney Disease"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1053\/j.ackd.2017.01.002","type":"journal-article","created":{"date-parts":[[2017,5,10]],"date-time":"2017-05-10T08:15:49Z","timestamp":1494404149000},"page":"154-161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["The Role of PET Scanning in the Evaluation of Patients With Kidney Disease"],"prefix":"10.1053","volume":"24","author":[{"given":"Namrata","family":"Krishnan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Perazella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1053\/j.ackd.2017.01.002_bib1","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/MAJ.0b013e3181f016e6","article-title":"Imaging patients with kidney disease: how\u00a0do we approach contrast-related toxicity?","volume":"341","author":"Perazella","year":"2011","journal-title":"Am J Med Sci"},{"issue":"4","key":"10.1053\/j.ackd.2017.01.002_bib2","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/j.semvascsurg.2014.06.001","article-title":"Renal imaging: duplex ultrasound, computed tomography angiography, magnetic resonance angiography, and angiography","volume":"26","author":"AbuRahma","year":"2013","journal-title":"Semin Vasc Surg"},{"issue":"6","key":"10.1053\/j.ackd.2017.01.002_bib3","doi-asserted-by":"crossref","first-page":"381","DOI":"10.5414\/CN108301","article-title":"Diagnosing drug-induced AIN in the hospitalized patient: a challenge for the clinician","volume":"81","author":"Perazella","year":"2014","journal-title":"Clin Nephrol"},{"issue":"2","key":"10.1053\/j.ackd.2017.01.002_bib4","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2214\/AJR.07.3629","article-title":"Retroperitoneal fibrosis: a review of clinical features and imaging findings","volume":"191","author":"Cronin","year":"2008","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"10.1053\/j.ackd.2017.01.002_bib5","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/ndt\/gfu227","article-title":"Diagnostic criteria in renal and hepatic cyst infection","volume":"30","author":"Lantinga","year":"2015","journal-title":"Nephrol Dialysis Transplant"},{"key":"10.1053\/j.ackd.2017.01.002_bib6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40644-015-0053-1","article-title":"Evidence-based medicine and clinical fluorodeoxyglucose PET\/MRI in oncology","volume":"15","author":"Miles","year":"2015","journal-title":"Cancer Imaging"},{"issue":"7","key":"10.1053\/j.ackd.2017.01.002_bib7","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.crad.2015.03.010","article-title":"FDG PET\/CT in infection and inflammation\u2014current and emerging clinical applications","volume":"70","author":"Vaidyanathan","year":"2015","journal-title":"Clin Radiol"},{"issue":"6","key":"10.1053\/j.ackd.2017.01.002_bib8","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.crad.2014.12.017","article-title":"Measuring myocardial perfusion: the role of PET, MRI and CT","volume":"70","author":"Qayyum","year":"2015","journal-title":"Clin Radiol"},{"issue":"2","key":"10.1053\/j.ackd.2017.01.002_bib9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.cpet.2013.10.006","article-title":"Brain: normal variations and benign findings in fluorodeoxyglucose-PET\/computed tomography imaging","volume":"9","author":"Berti","year":"2014","journal-title":"PET Clinics"},{"key":"10.1053\/j.ackd.2017.01.002_bib10","series-title":"Positron Emission Tomography: Basic Sciences","author":"Bailey","year":"2005"},{"issue":"3","key":"10.1053\/j.ackd.2017.01.002_bib11","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1053\/j.semnuclmed.2008.01.003","article-title":"Positron emission tomography\/computed tomography","volume":"38","author":"Townsend","year":"2008","journal-title":"Semin Nucl Med"},{"issue":"3","key":"10.1053\/j.ackd.2017.01.002_bib12","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1053\/snuc.2003.127314","article-title":"PET\/CT scanners: a hardware approach to image fusion","volume":"33","author":"Townsend","year":"2003","journal-title":"Semin Nucl Med"},{"issue":"2","key":"10.1053\/j.ackd.2017.01.002_bib13","first-page":"155","article-title":"Positron emission tomography combined with computed tomography (PET-CT) as a new diagnostic tool for acute tubulointerstitial nephritis (AIN) in oliguric or haemodialysed patients","volume":"3","author":"Katagiri","year":"2010","journal-title":"NDT Plus"},{"issue":"2","key":"10.1053\/j.ackd.2017.01.002_bib14","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2215\/CJN.03170313","article-title":"Renal relevant radiology: use of ultrasound in kidney disease and nephrology procedures","volume":"9","author":"O'Neill","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ackd.2017.01.002_bib15","first-page":"84","article-title":"Gallium67 scintigraphy in the diagnosis of acute renal disease","volume":"24","author":"Linton","year":"1985","journal-title":"Clin Nephrol"},{"issue":"7","key":"10.1053\/j.ackd.2017.01.002_bib16","first-page":"568","article-title":"Failure of Gallium-67 scintigraphy to identify reliably noninfectious interstitial nephritis: concise communication","volume":"24","author":"Graham","year":"1983","journal-title":"J Nucl Med"},{"issue":"6","key":"10.1053\/j.ackd.2017.01.002_bib17","first-page":"231","article-title":"Retroperitoneal fibrosis","volume":"60","author":"van Bommel","year":"2002","journal-title":"Neth J Med"},{"issue":"9506","key":"10.1053\/j.ackd.2017.01.002_bib18","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(06)68035-5","article-title":"Retroperitoneal fibrosis","volume":"367","author":"Vaglio","year":"2006","journal-title":"Lancet"},{"issue":"6","key":"10.1053\/j.ackd.2017.01.002_bib19","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/S0022-5347(17)69482-5","article-title":"Bilateral ureteral obstruction due to envelopment and compression by an inflammatory retroperitoneal process","volume":"59","author":"Ormond","year":"1948","journal-title":"J Urol"},{"issue":"1","key":"10.1053\/j.ackd.2017.01.002_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-5347(17)56223-0","article-title":"Idiopathic retroperitoneal fibrosis","volume":"122","author":"Lepor","year":"1979","journal-title":"J Urol"},{"issue":"3","key":"10.1053\/j.ackd.2017.01.002_bib21","first-page":"250","article-title":"The clinical significance of retroperitoneal fibrosis","volume":"81","author":"Koep","year":"1977","journal-title":"Surgery"},{"issue":"9419","key":"10.1053\/j.ackd.2017.01.002_bib22","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/S0140-6736(04)16100-X","article-title":"Asbestos exposure as a risk factor for retroperitoneal fibrosis","volume":"363","author":"Uibu","year":"2004","journal-title":"Lancet"},{"issue":"1","key":"10.1053\/j.ackd.2017.01.002_bib23","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/01.bor.0000145517.83972.40","article-title":"Chronic periaortitis: a spectrum of diseases","volume":"17","author":"Vaglio","year":"2005","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"10.1053\/j.ackd.2017.01.002_bib24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/MD.0b013e3181afc420","article-title":"Idiopathic retroperitoneal fibrosis: prospective evaluation of incidence and clinicoradiologic presentation","volume":"88","author":"van Bommel","year":"2009","journal-title":"Medicine"},{"issue":"4","key":"10.1053\/j.ackd.2017.01.002_bib25","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/MD.0b013e3181afc439","article-title":"Retroperitoneal fibrosis: the clinical, laboratory, and radiographic presentation","volume":"88","author":"Scheel","year":"2009","journal-title":"Medicine"},{"issue":"4","key":"10.1053\/j.ackd.2017.01.002_bib26","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/MD.0b013e3181afc4d1","article-title":"Retroperitoneal fibrosis: new insights into clinical presentation and diagnosis","volume":"88","author":"Vaglio","year":"2009","journal-title":"Medicine"},{"issue":"1","key":"10.1053\/j.ackd.2017.01.002_bib27","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1440-1673.2006.01654.x","article-title":"Imaging and intervention of retroperitoneal fibrosis","volume":"51","author":"Geoghegan","year":"2007","journal-title":"Australas Radiol"},{"issue":"2","key":"10.1053\/j.ackd.2017.01.002_bib28","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2214\/ajr.133.2.239","article-title":"Retroperitoneal fibrosis: ultrasound and CT features","volume":"133","author":"Fagan","year":"1979","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"10.1053\/j.ackd.2017.01.002_bib29","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0022-5347(17)54466-3","article-title":"Computerized tomography in the diagnosis of retroperitoneal fibrosis","volume":"126","author":"Feinstein","year":"1981","journal-title":"J Urol"},{"issue":"11","key":"10.1053\/j.ackd.2017.01.002_bib30","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/rheumatology\/keh326","article-title":"Chronic periaortitis","volume":"43","author":"Jois","year":"2004","journal-title":"Rheumatology (Oxford, England)"},{"issue":"2","key":"10.1053\/j.ackd.2017.01.002_bib31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF02927814","article-title":"Computed tomography in the diagnosis of retroperitoneal fibrosis","volume":"3","author":"Dalla-Palma","year":"1981","journal-title":"Urol Radiol"},{"issue":"2","key":"10.1053\/j.ackd.2017.01.002_bib32","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2214\/ajr.157.2.1853816","article-title":"Retroperitoneal fibrosis","volume":"157","author":"Amis","year":"1991","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"10.1053\/j.ackd.2017.01.002_bib33","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/sj.ki.5002427","article-title":"Idiopathic retroperitoneal fibrosis: clinicopathologic features and differential diagnosis","volume":"72","author":"Corradi","year":"2007","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ackd.2017.01.002_bib34","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1148\/radiology.172.1.2740497","article-title":"Malignant versus nonmalignant retroperitoneal fibrosis: differentiation with MR imaging","volume":"172","author":"Arrive","year":"1989","journal-title":"Radiology"},{"issue":"2","key":"10.1053\/j.ackd.2017.01.002_bib35","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1148\/radiol.14131565","article-title":"Role of diffusion-weighted MR imaging in the differentiation of benign retroperitoneal fibrosis from malignant neoplasm: preliminary study","volume":"272","author":"Bakir","year":"2014","journal-title":"Radiology"},{"issue":"10","key":"10.1053\/j.ackd.2017.01.002_bib36","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1007\/s00259-012-2144-6","article-title":"The value of (18)F-FDG PET\/CT in the assessment of active idiopathic retroperitoneal fibrosis","volume":"39","author":"Moroni","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1053\/j.ackd.2017.01.002_bib37","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/art.21074","article-title":"Positron emission tomography (PET): evaluation of chronic periaortitis","volume":"53","author":"Salvarani","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1053\/j.ackd.2017.01.002_bib38","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/art.20914","article-title":"(18)F-fluorodeoxyglucose positron emission tomography in the diagnosis and followup of idiopathic retroperitoneal fibrosis","volume":"53","author":"Vaglio","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1053\/j.ackd.2017.01.002_bib39","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/01.rlu.0000257295.12017.ab","article-title":"FDG PET and PET\/CT monitoring of autoimmune pancreatitis associated with extrapancreatic autoimmune disease","volume":"32","author":"Nakajo","year":"2007","journal-title":"Clin Nucl Med"},{"issue":"3","key":"10.1053\/j.ackd.2017.01.002_bib40","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s12149-010-0341-6","article-title":"(18)F-Fluorodeoxyglucose positron emission tomography for diagnosis and monitoring of idiopathic retroperitoneal fibrosis associated with mediastinal fibrosis","volume":"24","author":"Washino","year":"2010","journal-title":"Ann Nucl Med"},{"issue":"4","key":"10.1053\/j.ackd.2017.01.002_bib41","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0531-5565(02)00267-X","article-title":"18F-fluorodeoxyglucose-positron emission tomography: a new explorative perspective","volume":"38","author":"Schirmer","year":"2003","journal-title":"Exp Gerontol"},{"issue":"6","key":"10.1053\/j.ackd.2017.01.002_bib42","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/00003072-200206000-00005","article-title":"Riedel's thyroiditis and retroperitoneal fibrosis in multifocal fibrosclerosis: positron emission tomographic findings","volume":"27","author":"Drieskens","year":"2002","journal-title":"Clin Nucl Med"},{"issue":"1","key":"10.1053\/j.ackd.2017.01.002_bib43","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12149-007-0077-0","article-title":"Hypermetabolic activity in patients with active retroperitoneal fibrosis on F-18 FDG PET: report of three cases","volume":"22","author":"Young","year":"2008","journal-title":"Ann Nucl Med"},{"issue":"4","key":"10.1053\/j.ackd.2017.01.002_bib44","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/01.rct.0000284388.45579.05","article-title":"18F-fluorodeoxyglucose positron emission tomography features of idiopathic retroperitoneal fibrosis","volume":"31","author":"Nakajo","year":"2007","journal-title":"J Comput Assist Tomography"},{"issue":"3","key":"10.1053\/j.ackd.2017.01.002_bib45","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ejim.2010.02.008","article-title":"(18)F-fluorodeoxyglucose position emission tomography (FDG-PET) for monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis","volume":"21","author":"Jansen","year":"2010","journal-title":"Eur J Intern Med"},{"issue":"7","key":"10.1053\/j.ackd.2017.01.002_bib46","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2215\/CJN.01870309","article-title":"Cyst infections in patients with autosomal dominant polycystic kidney disease","volume":"4","author":"Sallee","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"10.1053\/j.ackd.2017.01.002_bib47","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.2215\/CJN.06900810","article-title":"Positron-emission computed tomography in cyst infection diagnosis in patients with autosomal dominant polycystic kidney disease","volume":"6","author":"Jouret","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2017.01.002_bib48","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1471-2369-12-48","article-title":"Positron emission tomography in the diagnostic pathway for intracystic infection in ADPKD and \u201ccystic\u201d kidneys. A case series","volume":"12","author":"Piccoli","year":"2011","journal-title":"BMC Nephrol"},{"issue":"4","key":"10.1053\/j.ackd.2017.01.002_bib49","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000446664","article-title":"International multi-specialty Delphi survey: identification of diagnostic criteria for hepatic and renal cyst infection","volume":"134","author":"Lantinga","year":"2016","journal-title":"Nephron"},{"issue":"8","key":"10.1053\/j.ackd.2017.01.002_bib50","doi-asserted-by":"crossref","first-page":"e0161277","DOI":"10.1371\/journal.pone.0161277","article-title":"Diagnostic algorithm in the management of acute febrile abdomen in patients with autosomal dominant polycystic kidney disease","volume":"11","author":"Neuville","year":"2016","journal-title":"PLoS One"},{"issue":"10","key":"10.1053\/j.ackd.2017.01.002_bib51","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1093\/ndt\/gfs352","article-title":"Diagnosis of cyst infection in patients with autosomal dominant polycystic kidney disease: attributes and limitations of the current modalities","volume":"27","author":"Jouret","year":"2012","journal-title":"Nephrol Dialysis Transplant"},{"issue":"1","key":"10.1053\/j.ackd.2017.01.002_bib52","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/ndt\/gfm665","article-title":"Renal cyst infection in autosomal dominant polycystic kidney disease","volume":"23","author":"Migali","year":"2008","journal-title":"Nephrol Dialysis Transplant"},{"issue":"11","key":"10.1053\/j.ackd.2017.01.002_bib53","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/j.1442-2042.2009.02387.x","article-title":"Diagnosis and localization of infected renal cyst by diffusion-weighted magnetic resonance imaging in polycystic kidney disease","volume":"16","author":"Kita","year":"2009","journal-title":"Int J Urol"},{"issue":"6","key":"10.1053\/j.ackd.2017.01.002_bib54","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.urology.2007.09.040","article-title":"Diffusion-weighted magnetic resonance imaging of infected renal cysts in a patient with polycystic kidney disease","volume":"70","author":"Ichioka","year":"2007","journal-title":"Urology"},{"issue":"Suppl 1","key":"10.1053\/j.ackd.2017.01.002_bib55","first-page":"24","article-title":"Efficacy of diffusion-weighted magnetic resonance imaging in detecting infected cysts in a case of polycystic kidney disease","volume":"75","author":"Katano","year":"2011","journal-title":"Clin Nephrol"},{"issue":"1","key":"10.1053\/j.ackd.2017.01.002_bib56","doi-asserted-by":"crossref","first-page":"61","DOI":"10.5414\/CN108495","article-title":"18F-FDG PET\/CT during diagnosis and follow-up of recurrent hepatic cyst infection in autosomal dominant polycystic kidney disease","volume":"84","author":"Lantinga","year":"2015","journal-title":"Clin Nephrol"},{"issue":"1","key":"10.1053\/j.ackd.2017.01.002_bib57","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cmi.2015.09.024","article-title":"Diagnostic performance of [(18)F]fluorodeoxyglucose positron emission tomography-computed tomography in cyst infection in patients with autosomal dominant polycystic kidney disease","volume":"22","author":"Bobot","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1053\/j.ackd.2017.01.002_bib58","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1102\/1470-7330.2012.0042","article-title":"Meta-analysis of the diagnostic performance of [18F]FDG-PET and PET\/CT in renal cell carcinoma","volume":"12","author":"Wang","year":"2012","journal-title":"Cancer Imaging"},{"issue":"1","key":"10.1053\/j.ackd.2017.01.002_bib59","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1442-2042.2002.00416.x","article-title":"Significance of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) for detection of renal cell carcinoma and immunohistochemical glucose transporter 1 (GLUT-1) expression in the cancer","volume":"9","author":"Miyakita","year":"2002","journal-title":"Int J Urol"},{"issue":"9","key":"10.1053\/j.ackd.2017.01.002_bib60","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1007\/s00259-003-1211-4","article-title":"Efficiency of [(18)F]FDG PET in characterising renal cancer and detecting distant metastases: a comparison with CT","volume":"30","author":"Aide","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.ackd.2017.01.002_bib61","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3389\/fonc.2016.00201","article-title":"The place of FDG PET\/CT in renal cell carcinoma: value and limitations","volume":"6","author":"Liu","year":"2016","journal-title":"Front Oncol"},{"issue":"6","key":"10.1053\/j.ackd.2017.01.002_bib62","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s11307-005-0026-z","article-title":"2-Deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography in characterization of solid renal masses","volume":"7","author":"Kumar","year":"2005","journal-title":"Mol Imaging Biol"},{"issue":"4","key":"10.1053\/j.ackd.2017.01.002_bib63","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/08998280.2005.11928089","article-title":"Use of PET\/CT scanning in cancer patients: technical and practical considerations","volume":"18","author":"Griffeth","year":"2005","journal-title":"Baylor Univ Medical Center Proc"},{"issue":"12","key":"10.1053\/j.ackd.2017.01.002_bib64","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1097\/RLU.0000000000000875","article-title":"Preoperative evaluation of renal cell carcinoma by using 18F-FDG PET\/CT","volume":"40","author":"Takahashi","year":"2015","journal-title":"Clin Nucl Med"},{"issue":"1","key":"10.1053\/j.ackd.2017.01.002_bib65","first-page":"19","article-title":"Assessment of the diagnostic performance of (18)F-FDG-PET\/CT for detection and characterization of solid renal malignancies","volume":"16","author":"Nakhoda","year":"2013","journal-title":"Hellenic J Nucl Med"},{"issue":"1","key":"10.1053\/j.ackd.2017.01.002_bib66","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejrad.2009.11.019","article-title":"The potential clinical value of FDG-PET for recurrent renal cell carcinoma","volume":"79","author":"Nakatani","year":"2011","journal-title":"Eur J Radiol"},{"issue":"6","key":"10.1053\/j.ackd.2017.01.002_bib67","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.clinimag.2012.01.010","article-title":"Spectrum of malignant renal and urinary bladder tumors on 18F-FDG PET\/CT: a pictorial essay","volume":"36","author":"Makis","year":"2012","journal-title":"Clin Imaging"},{"issue":"21","key":"10.1053\/j.ackd.2017.01.002_bib68","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1200\/JCO.2003.04.073","article-title":"F-18 fluorodeoxyglucose positron emission tomography in the evaluation of distant metastases from renal cell carcinoma","volume":"21","author":"Majhail","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.ackd.2017.01.002_bib69","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1186\/1471-2407-10-667","article-title":"Impact of maximum standardized uptake value (SUVmax) evaluated by 18-Fluoro-2-deoxy-D-glucose positron emission tomography\/computed tomography (18F-FDG-PET\/CT) on survival for patients with advanced renal cell carcinoma: a preliminary report","volume":"10","author":"Namura","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1053\/j.ackd.2017.01.002_bib70","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12885-016-2097-4","article-title":"FDG PET\/CT as a prognostic biomarker in the era of molecular-targeting therapies: max SUVmax predicts survival of patients with advanced renal cell carcinoma","volume":"16","author":"Nakaigawa","year":"2015","journal-title":"BMC Cancer"},{"issue":"18","key":"10.1053\/j.ackd.2017.01.002_bib71","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.1158\/1078-0432.CCR-10-3309","article-title":"Sequential FDG-PET\/CT as a biomarker of response to sunitinib in metastatic clear cell renal cancer","volume":"17","author":"Kayani","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1053\/j.ackd.2017.01.002_bib72","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/cam4.102","article-title":"FDG-PET as a predictive biomarker for therapy with everolimus in metastatic renal cell cancer","volume":"2","author":"Chen","year":"2013","journal-title":"Cancer Med"},{"key":"10.1053\/j.ackd.2017.01.002_bib73","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/1471-2407-12-162","article-title":"Early assessment by FDG-PET\/CT of patients with advanced renal cell carcinoma treated with tyrosine kinase inhibitors is predictive of disease course","volume":"12","author":"Ueno","year":"2012","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1053\/j.ackd.2017.01.002_bib74","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2478\/raon-2013-0067","article-title":"The role of fluorine-18-fluorodeoxyglucose positron emission tomography in evaluating the response to tyrosine-kinase inhibitors in patients with metastatic primary renal cell carcinoma","volume":"48","author":"Caldarella","year":"2014","journal-title":"Radiol Oncol"}],"container-title":["Advances in Chronic Kidney Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559517300022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559517300022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T04:59:03Z","timestamp":1569301143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1548559517300022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":74,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S1548559517300022"],"URL":"https:\/\/doi.org\/10.1053\/j.ackd.2017.01.002","relation":{},"ISSN":["1548-5595"],"issn-type":[{"value":"1548-5595","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of PET Scanning in the Evaluation of Patients With Kidney Disease","name":"articletitle","label":"Article Title"},{"value":"Advances in Chronic Kidney Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ackd.2017.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the National Kidney Foundation, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}